EMBioSys

Curated by Signal

Biomedical technology company developing non-invasive therapies for the treatment of metastatic cancer

Overview

EMBioSys is a medical technology company focused on developing non-invasive therapies for the treatment of metastatic cancer. The company's technology utilizes induced electric fields to modulate the immune tumor microenvironment, inhibiting breast cancer growth and metastasis. With a strong scientific foundation and a team of experienced experts, EMBioSys aims to revolutionize cancer treatment with its innovative approach.

Key facts

Founded: 2022
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Harmon Care
Provider of virtual therapy and mental care services for senior citizens
Health TechnologyNew York City, United States
Fair Dental
Online shop for dental supplies
Health TechnologyMiddletown, United States
Enalan
Provider of digital therapeutics software for chronic health treatment
Health TechnologyFort Lauderdale, United States

About EMBioSys

What does EMBioSys do?

EMBioSys is a medical technology company focused on developing non-invasive therapies for the treatment of metastatic cancer.

Where is EMBioSys headquartered?

EMBioSys is headquartered in Boston, United States.

When was EMBioSys founded?

EMBioSys was founded in 2022.

Which sector is EMBioSys in?

EMBioSys operates in Health Technology.

Who are EMBioSys's competitors?

Companies similar to EMBioSys include Harmon Care, Fair Dental, and Enalan.